| Mass Spectrometry Techniques and Applications | Lifetime | 7 | NL 1 | 99.94 |
| Advanced Proteomics Techniques and Applications | Lifetime | 7 | NL 1 | 99.85 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 34 | NL 2 | 99.64 |
| Glycosylation and Glycoproteins Research | Lifetime | 104 | NL 5 | 99.44 |
| Analytical Chemistry and Chromatography | Lifetime | 138 | NL 3 | 99.51 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 385 | NL 12 | 99.28 |
| Enzyme Structure and Function | Lifetime | 168 | NL 4 | 99.19 |
| Peptidase Inhibition and Analysis | Lifetime | 322 | NL 9 | 98.71 |
| Protein purification and stability | Lifetime | 125 | NL 6 | 98.41 |
| Ubiquitin and proteasome pathways | Lifetime | 370 | NL 10 | 98.30 |
| RNA and protein synthesis mechanisms | Lifetime | 777 | NL 14 | 98.47 |
| Bacteriophages and microbial interactions | Lifetime | 827 | NL 27 | 97.68 |
| Molecular Biology Techniques and Applications | Lifetime | 589 | NL 25 | 96.02 |
| Protein Structure and Dynamics | Lifetime | 690 | NL 16 | 97.52 |
| Ion-surface interactions and analysis | Lifetime | 801 | NL 20 | 96.58 |
| Advanced Biosensing Techniques and Applications | Lifetime | 401 | NL 4 | 94.99 |
| vaccines and immunoinformatics approaches | Lifetime | 606 | NL 24 | 94.04 |
| Phosphodiesterase function and regulation | Lifetime | 632 | NL 20 | 85.80 |
| Glycosylation and Glycoproteins Research | 2021-2025 | 11 | NL 3 | 98.84 |
| Mass Spectrometry Techniques and Applications | 2021-2025 | 11 | NL 2 | 99.12 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 36 | NL 4 | 98.97 |
| Advanced Proteomics Techniques and Applications | 2021-2025 | 36 | NL 2 | 96.76 |
| Ion-surface interactions and analysis | 2021-2025 | 111 | NL 3 | 90.51 |
| Peptidase Inhibition and Analysis | 2021-2025 | 461 | NL 8 | 91.78 |
| Blood groups and transfusion | 2021-2025 | 191 | NL 15 | 91.69 |
| Mitochondrial Function and Pathology | 2021-2025 | 812 | NL 15 | 87.19 |
| Infant Nutrition and Health | 2021-2025 | 363 | NL 22 | 88.07 |
| Complement system in diseases | 2021-2025 | 411 | NL 28 | 82.16 |
| vaccines and immunoinformatics approaches | 2021-2025 | 750 | NL 3 | 77.02 |
| Galectins and Cancer Biology | 2021-2025 | 709 | NL 27 | 69.23 |
| Protein purification and stability | 2021-2025 | 914 | NL 22 | 61.79 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 879 | NL 15 | 55.29 |
